Leigh-Anne Lagden was given a free weight loss injection in exchange for social media promotion but claims they told her to ...

Microdosing isn’t nearly as easy with tirzepatide (Mounjaro ... and using the incorrect click chart could result in a very wrong and possibly dangerous dose. These risks are likely more serious ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Chart: The Economist What is more ... been reluctant to cover the cost of using GLP-1s for weight loss (a smaller dose is prescribed for diabetes). In America, the largest market by far for ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reductio ...

Tirzepatide by Eli Lilly reduces heart failure risk in adults with HFpEF and obesity, showing promising results for both ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

The current analysis involved the participants with both obesity and prediabetes, who received their assigned dose of tirzepatide or placebo for a total of 176 weeks, followed by a 17-week off ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Jaime Merchan, MD, discusses the background and findings from the LITESPARK-013 trial of belzutifan for the treatment of patients with advanced clear cell renal cell carcinoma.

A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe ...